Home »
OUR SERVICES
Our molecule sub-screening service focuses
on the refinement and repurposing of screened drugs.
We offer a complete process for refining and repurposing previously approved drugs or those in development for new medical applications. This process, known as "drug repurposing" or "repositioning," involves identifying new uses for existing drugs beyond their original approved indications. This includes proprietary drugs from pharmaceutical companies that did not pass clinical trials.
We have applied for two European patents to protect our unique approach and for the protection of therapeutic XCI-reactivating molecules and we are in progress to apply for another patent for our proprietary AI-powered RNA modifying molecule discovery platform.
